Merit Financial Group LLC grew its stake in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 268.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,181 shares of the company's stock after purchasing an additional 3,047 shares during the quarter. Merit Financial Group LLC's holdings in Molina Healthcare were worth $1,377,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of MOH. Rothschild Investment LLC lifted its stake in shares of Molina Healthcare by 126.3% in the first quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after acquiring an additional 48 shares in the last quarter. Colonial Trust Co SC lifted its stake in shares of Molina Healthcare by 930.0% in the fourth quarter. Colonial Trust Co SC now owns 103 shares of the company's stock worth $30,000 after acquiring an additional 93 shares in the last quarter. Wingate Wealth Advisors Inc. acquired a new position in shares of Molina Healthcare in the fourth quarter worth about $52,000. Hurley Capital LLC acquired a new position in shares of Molina Healthcare in the fourth quarter worth about $55,000. Finally, EverSource Wealth Advisors LLC lifted its stake in shares of Molina Healthcare by 81.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after acquiring an additional 88 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company's stock.
Analysts Set New Price Targets
MOH has been the topic of several recent analyst reports. UBS Group cut their price target on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a research note on Friday, February 7th. Sanford C. Bernstein started coverage on Molina Healthcare in a research note on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 price objective on the stock. Baird R W cut Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Robert W. Baird restated a "neutral" rating and set a $375.00 price objective (up previously from $331.00) on shares of Molina Healthcare in a research note on Tuesday, April 15th. Finally, Truist Financial upped their price objective on Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a research note on Friday, April 11th. Nine research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, Molina Healthcare currently has an average rating of "Hold" and an average target price of $364.54.
Read Our Latest Stock Report on Molina Healthcare
Insider Activity
In related news, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the sale, the chief executive officer now owns 257,715 shares in the company, valued at approximately $82,484,262.90. This trade represents a 25.35% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Richard M. Schapiro sold 669 shares of the firm's stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the sale, the director now owns 11,244 shares in the company, valued at $3,603,702. This represents a 5.62% decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is owned by insiders.
Molina Healthcare Price Performance
MOH opened at $296.16 on Friday. The company has a fifty day moving average price of $320.53 and a two-hundred day moving average price of $307.19. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. Molina Healthcare, Inc. has a 52 week low of $262.32 and a 52 week high of $365.23. The firm has a market capitalization of $16.05 billion, a PE ratio of 14.50, a P/E/G ratio of 1.06 and a beta of 0.56.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.96 by $0.12. The company had revenue of $11.15 billion during the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The firm's revenue was up 12.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.73 EPS. As a group, analysts anticipate that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.